Saturday, January 12, 2019 6:23:59 AM
- "The value of the total consideration ultimately expected to be received by Amarantus from Coeptis upon this sale is greater than all of the Company's outstanding liabilities combined."
- look who IDEA clients are; Boehringer Ingelheim, Bristol, J&J, Novartis, Pfizer, Roche, and many more
- IDEA has 6k Followers on LinkedIn, 10x AMBS
- manf is still ours
- everything seems to move in the right direction
happy for the new investors that will arrive .... I emphasize investors .... unfortunately will come many "hit and run" .... without having understood what they had in the portfolio .... at miserable 100 million market cap we would be 20x the current evaluation ....
lucky who buys these figures
greetings from Italy
Paolo
Ps
ebenizer sid and j petro you are commendable ... I respect you ... I am under 97% and I do not feel any negative sentiment towards the management, I find that the world of small start up can give satisfactions but, more often , many disappointments ..... I have always had confidence in the science of ambs ....
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM